2-HYDROXYSACLOFEN
2-HYDROXYSACLOFEN Basic information
- Product Name:
- 2-HYDROXYSACLOFEN
- Synonyms:
-
- HYDROXYSACLOFEN
- 3-amino-2-(4-chlorophenyl)-2-hydroxy-*propanesulf
- 2-HYDROXYSACLOFEN GABA(B) RECEPTOR ANTA
- 3-AMINO-2-(4-CHLOROPHENYL)-2-HYDROXY-PRO PANESULFON
- 2-HYDROXYSACLOFEN, >99%
- 3-Amino-2-(4-chlorophenyl)-2-hydroxypropane-1-sulfonic acid
- 3-Amino-2-hydroxy-2-(4-chlorophenyl)propane-1-sulfonic acid
- 2-Oh-saclofen
- CAS:
- 117354-64-0
- MF:
- C9H12ClNO4S
- MW:
- 265.71
- Product Categories:
-
- GABA/Glycine receptor
- Mol File:
- 117354-64-0.mol
2-HYDROXYSACLOFEN Chemical Properties
- Melting point:
- 267-269 °C
- RTECS
- DA0359200
- storage temp.
- 2-8°C
- solubility
- H2O: 1 mg/mL
- form
- solid
- color
- white
- Water Solubility
- Soluble in water at 1mg/ml. Also soluble in DMSO, 0.1M HCl and methanol
Safety Information
- Hazard Codes
- C
- Risk Statements
- 34
- Safety Statements
- 26-27-36/37/39-45
- RIDADR
- UN 1759 8/PG 3
- WGK Germany
- 3
- HazardClass
- 8
MSDS
- Language:English Provider:SigmaAldrich
2-HYDROXYSACLOFEN Usage And Synthesis
Uses
2-Hydroxysaclofen is a GABA-B receptor antagonist in the ventral tegmental area and may play a role in the mechanisms of cocaine usage. Affects specific acute nicotine responses in mice, abolishing hypolocomotion and increasing antinociception.
Definition
ChEBI: 3-amino-2-(4-chlorophenyl)-2-hydroxy-1-propanesulfonic acid is an organochlorine compound.
Biological Activity
Selective antagonist at GABA B receptors.
in vivo
2-Hydroxysaclofen (0.25-1 mg/kg; IP; single dosage) abolishes nicotine hypolocomotor effects and increases the antinociceptive effects of nicotine[1].
2-Hydroxysaclofen (0.3-3 mg/kg; IP; single dosage) reduces the effects of Baclofen (a GABA receptor agonist) on d-amphetamine-induced discriminative cue[2].
2-Hydroxysaclofen (0-100 μg/2 μl; ICV; single dosage) produces a rapid elevation in the serum LH concentration in the estrogen-primed ovariectomized rat[3].
| Animal Model: | Male Swiss Webster mice (22-24 g; treated with 3 mg/kg nicotine)[1] |
| Dosage: | 0.25, 0.5 and 1 mg/kg |
| Administration: | IP; single dosage; after 10 or 45 min of nicotine administration |
| Result: | Abolished nicotine hypolocomotor effects at 1 mg/kg, and increased the antinociceptive effects of nicotine at 1 mg/kg. |
| Animal Model: | Male Wistar rats[2] |
| Dosage: | 0.3, 1 and 3 mg/kg |
| Administration: | IP; single dosage |
| Result: | Reduced the effects of Baclofen on d-amphetamine-induced discriminative cue. |
| Animal Model: | Female Wistar rats (8 weeks)[3] |
| Dosage: | 0, 20, 50 or 100 μg/2 μL |
| Administration: | ICV; single dosage |
| Result: | Produced a rapid elevation in the serum LH concentration in the estrogen-primed ovariectomized rat with a dose-dependent manner, and the peak LH values were observed 10 min after the injection. The effect was dose-dependent, as 0 or 20 μg of the antagonist was ineffective while a pronounced effect was observed after the injection of 50 or 100 μg. |
storage
Store at RT
2-HYDROXYSACLOFENSupplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 020-39119399 18927568969
- isunpharm@qq.com
- Tel
- +1 (866) 930-6790
- info@adooq.com
- Tel
- info@bocsci.com